Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Maria Gonzalez-Angulo

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
Evaluating breast cancer risk with genome-wide association studies: is this approach patient ready?Jennifer K Litton, Ana Maria Gonzalez-Angulo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Targeting the mTOR signaling network for cancer therapyFunda Meric-Bernstam, Ana Maria Gonzalez-Angulo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2005
Inflammatory breast cancer and high-dose chemotherapy: back to the pastAna Maria Gonzalez-Angulo, Paolo Morandi, Massimo Cristofanilli
Ochsner Journal|July 24, 2012
Cyclooxygenase 2 inhibitors and colon cancerAna Maria Gonzalez-Angulo, Jyotsna Fuloria, Om Prakash
Advances in Experimental Medicine and Biology|November 13, 2007
Overview of resistance to systemic therapy in patients with breast cancerAna Maria Gonzalez-Angulo, Flavia Morales-Vasquez, Gabriel N Hortobagyi
Nature Clinical Practice. Oncology|December 13, 2005
Individualization of neoadjuvant therapy for breast cancer according to molecular tumor characteristicsBryan T Hennessy, Ana Maria Gonzalez-Angulo, Gabriel N Hortobagyi
Seminars in Roentgenology|December 8, 2010
Triple-negative breast cancer: what the radiologist needs to knowGary J Whitman, Constance T Albarracin, Ana Maria Gonzalez-Angulo
Translational Lung Cancer Research|March 26, 2015
Role of HGF/MET axis in resistance of lung cancer to contemporary managementKanwal Pratap Singh Raghav, Ana Maria Gonzalez-Angulo, George R Blumenschein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Future of personalized medicine in oncology: a systems biology approachAna Maria Gonzalez-Angulo, Bryan T J Hennessy, Gordon B Mills
Cancer Treatment Reviews|October 2, 2013
HER2 testing: current status and future directionsEdith A Perez, Javier Cortés, Ana Maria Gonzalez-Angulo, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2012
Evaluating breast cancer risk with genome-wide association studies: is this approach patient ready?Jennifer K Litton, Ana Maria Gonzalez-Angulo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Targeting the mTOR signaling network for cancer therapyFunda Meric-Bernstam, Ana Maria Gonzalez-Angulo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2005
Inflammatory breast cancer and high-dose chemotherapy: back to the pastAna Maria Gonzalez-Angulo, Paolo Morandi, Massimo Cristofanilli
Ochsner Journal|July 24, 2012
Cyclooxygenase 2 inhibitors and colon cancerAna Maria Gonzalez-Angulo, Jyotsna Fuloria, Om Prakash
Advances in Experimental Medicine and Biology|November 13, 2007
Overview of resistance to systemic therapy in patients with breast cancerAna Maria Gonzalez-Angulo, Flavia Morales-Vasquez, Gabriel N Hortobagyi
Nature Clinical Practice. Oncology|December 13, 2005
Individualization of neoadjuvant therapy for breast cancer according to molecular tumor characteristicsBryan T Hennessy, Ana Maria Gonzalez-Angulo, Gabriel N Hortobagyi
Seminars in Roentgenology|December 8, 2010
Triple-negative breast cancer: what the radiologist needs to knowGary J Whitman, Constance T Albarracin, Ana Maria Gonzalez-Angulo
Translational Lung Cancer Research|March 26, 2015
Role of HGF/MET axis in resistance of lung cancer to contemporary managementKanwal Pratap Singh Raghav, Ana Maria Gonzalez-Angulo, George R Blumenschein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Future of personalized medicine in oncology: a systems biology approachAna Maria Gonzalez-Angulo, Bryan T J Hennessy, Gordon B Mills
Cancer Treatment Reviews|October 2, 2013
HER2 testing: current status and future directionsEdith A Perez, Javier Cortés, Ana Maria Gonzalez-Angulo, et al.
Pageof 8